- Home
- VCEL vs SENS Comparison
VCEL vs SENS Comparison
Compare VCEL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SENS
- Stock Information
- Founded
- VCEL 1989
- SENS 1996
- Country
- VCEL United States
- SENS United States
- Employees
- VCEL N/A
- SENS N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SENS Industrial Machinery/Components
- Sector
- VCEL Health Care
- SENS Industrials
- Exchange
- VCEL Nasdaq
- SENS Nasdaq
- Market Cap
- VCEL N/A
- SENS 179.7M
- IPO Year
- VCEL 1997
- SENS N/A
- Fundamental
- Price
- VCEL $56.50
- SENS $0.47
- Analyst Decision
- VCEL Strong Buy
- SENS Strong Buy
- Analyst Count
- VCEL 6
- SENS 1
- Target Price
- VCEL $61.83
- SENS $2.00
- AVG Volume (30 Days)
- VCEL 372.1K
- SENS 12.6M
- Earning Date
- VCEL 11-07-2024
- SENS 11-07-2024
- Dividend Yield
- VCEL N/A
- SENS N/A
- EPS Growth
- VCEL N/A
- SENS N/A
- EPS
- VCEL 0.07
- SENS N/A
- Revenue
- VCEL $226,844,000.00
- SENS $22,205,000.00
- Revenue This Year
- VCEL $23.82
- SENS $1.05
- Revenue Next Year
- VCEL $22.51
- SENS $61.23
- P/E Ratio
- VCEL $780.16
- SENS N/A
- Revenue Growth
- VCEL 22.48
- SENS 11.41
- 52 Week Low
- VCEL $32.31
- SENS $0.25
- 52 Week High
- VCEL $61.49
- SENS $0.75
- Technical
- Relative Strength Index (RSI)
- VCEL 54.70
- SENS 68.29
- Support Level
- VCEL $54.17
- SENS $0.40
- Resistance Level
- VCEL $59.47
- SENS $0.46
- Average True Range (ATR)
- VCEL 2.50
- SENS 0.05
- MACD
- VCEL -0.61
- SENS 0.01
- Stochastic Oscillator
- VCEL 40.31
- SENS 71.19
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.